Humanin and mouse lifespan: a mouse survival test in an existing paper was newly verified
What WPF says today
Humanin extending lifespan is Overstated: genetic overexpression extended worm lifespan, and in the one mouse lifespan test found, a humanin analogue started in middle age did not change survival. There is no human treatment trial.
Claim check: Humanin and longevity (humanin-extends-lifespan)
What this change did to the conclusion
Existing source newly verified. WPF read part of an existing publication that it had not read before and recorded what it found. The science did not change; WPF's knowledge of it did.
Verdict: unchanged (Overstated)
The verdict stayed Overstated. The earlier version said no mouse lifespan result was found in the abstracts read; checking Figure 3F established that the paper did test mouse lifespan and found no significant difference. That is a null result, which fits an overstated claim. WPF newly verified an experiment that already existed in a paper published in 2020; the paper did not change.
Before and after
Earlier: version 1.4.0 (the same wording appeared in 1.1.0 to 1.3.0)
- Gap: "A lifespan (survival) result in mice was not found in the abstracts WPF read."
- Limit: "WPF read abstracts, not full texts, so effect sizes and controls in each study are not assessed."
- Locator: "The abstract reports no mouse lifespan extension."
Now: version 1.5.0
- Full text read: female mice began treatment at 18 months of age and were treated for 14 months; "no significant difference in lifespans between the groups (Figure 3F)"; the two survival curves overlap from about 21 to 33 months.
- Also recorded: lower IGF-I and a trend for lower leptin in the treated group, and the authors' caveat that the null result may reflect a sub-optimal dosage or a late start.
- Limit now: the full text of this one paper was read; the other two sources were read as abstracts, and the other 18 longevity-related records were not read in full.
Exact records. Earlier: Claim record, version 1.4.0 (sha256 30f33c7a…) · Claim record, version 1.1.0 (first version with this check) (sha256 8c843883…). Updated: Claim record, version 1.5.0 (as published 2026-11-16) (sha256 c9b135e3…).
Where to verify it
- Aging (Albany NY) 2020, PMID 32575074 (PMC7343442): Figure 3, panel F (Survival), and its legend: "no significant difference in lifespan"
- Same paper, full text: Results, "Humanin treatment in middle-aged mice improves metabolic health": "After 14-months of treatment, there was no significant difference in lifespans between the groups (Figure 3F)"; Methods, "Humanin mouse lifespan study"; Discussion, the sub-optimal dosage and late-start caveat
Dates
- Original paper published (Aging, PMID 32575074): . Unchanged. WPF's earlier versions read only its abstract.
- WPF verified the source for this change:
- WPF published the corrected version:
Limits and review status
- The PubMed and ClinicalTrials.gov searches behind this check were not rerun on 2026-11-16, so its search date stays 2026-11-14.
- One analogue, one sex and one start age were tested; the authors themselves say the result does not show that humanin cannot change lifespan in mice.
- Dose figures are deliberately not reproduced.
Review status: AI-assisted source verification. Documented human review: none recorded. This is not scientific review and not attribution to a named reviewer.
Formal record: Correction Log entry.
Cite this change
World Peptide Foundation. "Humanin and mouse lifespan: a mouse survival test in an existing paper was newly verified". Change record humanin-mouse-lifespan-fig-3f, published 2026-11-16; WPF verified the source on 2026-11-16. Affected records: humanin-extends-lifespan. Change type: Existing source newly verified. Versions: 1.4.0 to 1.5.0. AI-assisted source verification; documented human review: none recorded. https://www.worldpeptidefoundation.org/research/changes/humanin-mouse-lifespan-fig-3f